Archives
- 2018-07
- 2018-10
- 2018-11
- 2019-04
- 2019-05
- 2019-06
- 2019-07
- 2019-08
- 2019-09
- 2019-10
- 2019-11
- 2019-12
- 2020-01
- 2020-02
- 2020-03
- 2020-04
- 2020-05
- 2020-06
- 2020-07
- 2020-08
- 2020-09
- 2020-10
- 2020-11
- 2020-12
- 2021-01
- 2021-02
- 2021-03
- 2021-04
- 2021-05
- 2021-06
- 2021-07
- 2021-08
- 2021-09
- 2021-10
- 2021-11
- 2021-12
- 2022-01
- 2022-02
- 2022-03
- 2022-04
- 2022-05
- 2022-06
- 2022-07
- 2022-08
- 2022-09
- 2022-10
- 2022-11
- 2022-12
- 2023-01
- 2023-02
- 2023-03
- 2023-04
- 2023-05
- 2023-06
- 2023-07
- 2023-08
- 2023-09
- 2023-10
- 2023-11
- 2023-12
- 2024-01
- 2024-02
- 2024-03
- 2024-04
- 2024-05
- 2024-06
- 2024-07
- 2024-08
- 2024-09
- 2024-10
- 2024-11
- 2024-12
- 2025-01
-
br Experimental Procedures br Author Contributions br Acknow
2018-10-20
Experimental Procedures Author Contributions Acknowledgments Introduction Nuclear reprogramming of somatic rho kinase inhibitor using genetic modification and overexpression of pluripotent transcription factors is essential for creating induced pluripotent stem cells (iPSCs) in vitro (T
-
It is often pointed out
2018-10-20
It is often pointed out that tumor alcohol dehydrogenase inhibitor can escape immune cells by changing their antigenicity through the modification of targeted peptide sequences or reduction of HLA-molecule expression (Schreiber et al., 2011). This is usually the case when immune therapies with anti
-
br Experimental Procedures br Author Contributions br Acknow
2018-10-20
Experimental Procedures Author Contributions Acknowledgments The authors would like to thank the many people who contributed to this glycosylase inhibitor project , with numerous feedback and involvement. We thank the Australian Genome Research Facility for running microarray samples; thank
-
Hello world!
2018-07-29
15814 records 1055/1055 page Previous First page 上5页 10511052105310541055